Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Nuformix plc Nuformix plc

Nuformix plc

NFX
Peringkat dalam Saham #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Harga Saham
$0.00185055
Kapitalisasi Pasar
$48.29K
Perubahan (1 hari)
-3.55%
Perubahan (1 tahun)
30.31%
Negara
GB
Perdagangan Nuformix plc (NFX)

Kategori

Healthcare
Rasio P/B untuk Nuformix plc (NFX)
Rasio P/B per September 2026 TTM: 2.01
Menurut laporan keuangan dan harga saham terbaru dari Nuformix plc, rasio P/B saat ini (TTM) adalah 2.01. Pada akhir 2024, rasio P/B perusahaan adalah 0.64.
Riwayat rasio P/B untuk Nuformix plc dari 2014 hingga 2026
Rasio P/B pada akhir setiap tahun
Tahun Rasio P/B Mengubah
2026 (TTM) 2.01 -61.14%
2025 5.17 703.62%
2024 0.64 44.29%
2023 0.45 -63.79%
2022 1.23 -46.40%
2021 2.30 -42.90%
2020 4.02 28.15%
2019 3.14 93.67%
2018 1.62 -108.69%
2017 -18.66 -793.31%
2016 2.69 0.00%
2014 0.00 0.00%
Rasio P/B untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/B Perbedaan Rasio P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.5144 224.23%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 8.5918 327.62%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 3.9974 98.95%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3983 268.22%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH